Back
Corporate News
Hester Biosciences’ revenue rose 14% to Rs 634.90 million, boosted by a Gates Foundation loan amendment
30-Jul-2026, 12:38
Hester Biosciences reported standalone revenue of Rs 634.90 million for the quarter ended June 30, 2026, a 14% increase compared to Rs 524.69 million in the corresponding quarter of the previous year, while standalone profit increased by 88%. Consolidated revenue decreased to Rs 772.44 million compared to Rs 841.05 million in the prior year, but consolidated profit rose significantly by 459% due to an exceptional gain of Rs 853.49 million from an amendment to a Gates Foundation loan for Hester Africa, which reduced the outstanding loan from USD 12.0 million to USD 5.0 million.
Hester Biosciences reported standalone revenue of Rs 634.90 million for the quarter ended June 30, 2026, a 14% increase compared to Rs 524.69 million in the corresponding quarter of the previous year, while standalone profit increased by 88%. Consolidated revenue decreased to Rs 772.44 million compared to Rs 841.05 million in the prior year, but consolidated profit rose significantly by 459% due to an exceptional gain of Rs 853.49 million from an amendment to a Gates Foundation loan for Hester Africa, which reduced the outstanding loan from USD 12.0 million to USD 5.0 million.